Walbert Keli — SEC Form 4 filings

SEC reporting owner CIK 2051489. 5 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-01-10 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Apellis Pharmaceuticals, Inc. (APLS)Director310
SPRUCE BIOSCIENCES, INC. (SPRB)Director22

Form 4 filings — Walbert Keli

FiledFormIssuerReported transactionsSource
2026-05-264SPRUCE BIOSCIENCES, INC. (SPRB)Grant/award (A): 1,700 (derivative) @ $0EDGAR
2026-05-144Apellis Pharmaceuticals, Inc. (APLS)Code (U): 17,051 · Disposition to issuer (D): 8,332 · Disposition to issuer (D): 664 · Disposition to issuer (D): 7,297 · Disposition to issuer (D): 14,684 (derivative) · Disposition to issuer (D): 15,388 (derivative)EDGAR
2026-01-054Apellis Pharmaceuticals, Inc. (APLS)Grant/award (A): 7,961 @ $0 · Grant/award (A): 14,684 (derivative) @ $0EDGAR
2025-12-154SPRUCE BIOSCIENCES, INC. (SPRB)Grant/award (A): 3,400 (derivative) @ $0EDGAR
2025-01-104Apellis Pharmaceuticals, Inc. (APLS)Grant/award (A): 9,090 @ $0 · Grant/award (A): 15,388 (derivative) @ $33EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2051489 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →